[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100430800":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":40,"responsibleParty":70,"collaborators":74,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":18,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":90,"maxAge":18,"enrollmentInfo":91,"targetDuration":18,"studyType":94,"phases":95,"briefSummary":97,"conditions":98,"keywords":100,"overallStatus":43,"whyStopped":18,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"CHU de Quebec-Universite Laval","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Exposed FMGs to GPS intervention","EXPERIMENTAL","Patients who are followed by FMGs exposed to the GPS intervention. They will receive the GPS intervention.",[13],"Other: GPS clinical intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Non exposed FMGs to GPS intervention","NO_INTERVENTION","Patients who are part of the FMGs not exposed to the GPS intervention. They will receive the usual care and services.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"GPS clinical intervention","Nurses and doctors in exposed FMGs and home care teams (HCTs) will be asked to refer to the FMG pharmacist all seniors undergoing cognitive evaluation OR referred to a memory clinic OR recently diagnosed with a cognitive disorder, for a complete and critical review of their medication therapy. FMG pharmacists will be asked to conduct an interview with each referred senior and his or her caregiver, if applicable, in order to establish the best possible treatment regimen. They will compare the information collected with another reliable data source (e.g., pharmacy records) in order to perform medication reconciliation and will then evaluate the medication related problems. Pharmacist will establish a care plan and the follow-ups to be carried out with the patient in collaboration with the health care team. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.",[9],[25],{"name":26,"affiliation":27,"role":28},"Line Guénette, Ph.D","CHU de Québec-Université Laval, Laval University","STUDY_DIRECTOR",[30,35],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","418-682-7511","84694","line.guenette@pha.ulaval.ca",{"name":36,"role":31,"phone":37,"phoneExt":38,"email":39},"Edeltraut Kröger, Ph.D","418-525-4444","84834","edeltraut.kroger.ciussscn@ssss.gouv.qc.ca",[41,57],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"GMF Bordeaux-Cartierville","RECRUITING","Montreal","Quebec","H3M 2X6","Canada","CA",{"type":50,"coordinates":51},"Point",[52,53],-73.58781,45.50884,{"lat":53,"lon":52},[56],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},{"facility":58,"status":43,"city":59,"state":45,"zip":60,"country":47,"countryCode":48,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"GMF Abénakis","Saint-Georges","G5Y 5L6",{"type":50,"coordinates":62},[63,64],-70.66526,46.11353,{"lat":64,"lon":63},[67,68],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},{"name":36,"role":69,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"type":71,"investigatorFullName":72,"investigatorTitle":73,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Dre Edeltraut Kröger","Professor",[75,78,80],{"name":76,"class":77},"CISSS de Chaudière-Appalaches","OTHER_GOV",{"name":79,"class":6},"Ciusss de L'Est de l'Île de Montréal",{"name":81,"class":77},"Fonds de la Recherche en Santé du Québec","100430800","gps-project-evaluation-of-the-impact-of-the-reorganization-of-work-into-a-family-medicine-group-on-pharmacotherapy-and-support-for-the-autonomy-of-seniors-with-major-neurocognitive-disorders-100430800",false,"NCT04889794","GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders","GPS Project - Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders","Inclusion Criteria:\n\n* All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND,\n* referred to the pharmacist, for the FMGs exposed\n* taking prescription medications\n\nExclusion Criteria:\n\n* Seniors in palliative care OR\n* unable to answer questionnaires in French AND without a caregiver.","ALL","65 Years",{"count":92,"type":93},400,"ESTIMATED","INTERVENTIONAL",[96],"NA","The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.",[99],"Major Neurocognitive Disorder",[101,102,103,104,105,106,107,108],"living lab","major neurocognitive disorder","polypharmacy","health outcomes","pharmacists","home care","family medicine groups","deprescribing","2024-08-20",{"date":111,"type":112},"2024-08-22","ACTUAL",{"date":114,"type":112},"2021-09-27",{"date":116,"type":93},"2026-12",{"name":5,"class":6},2]